Phase 3 ICARIA-MM Trial

Phase 3 ICARIA-MM Trial

obr

1 month
13 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Parameswaran Hari, MD Chief, Professor, Hematology/Medical Oncology, Medical College of Wisconsin, offers insight of the Phase 3 ICARIA-MM trial investigating isatuximab in relapsed/refractory multiple myeloma.
Up Next Autoplay